We investigated the polymorphisms of the promoter region of the MBL2 gene, which codifies for the Mannose-binding protein (MBP). The study population included 90 children with vertically acquired HIV-infection, further divided on the basis of the disease rate, 27 HIV exposed-uninfected children, and 74 healthy control subjects matched for ethnic origin to evaluate the MBP involvement in the risk of HIV-1 infection and to assess the role of the MBP promoter in AIDS progression. A region of 380 bp in the promoter of the MBL2 gene was analysed by PCR and direct sequencing of both DNA strands. We found that the polymorphism at position −550 influences the risk of HIV-infection and AIDS progression. Also a 6 bp deletion at position −328 was correlated with HIV-1 infection. This study indicates that the promoter of the MBL2 gene influences vertical transmission of HIV and the course of perinatal infection. Genes and Immunity (2000) 1, 346-348.
Introduction
The Mannose-binding protein (MBP), codified by the MBL2 gene, is a serum lectin, which takes part in natural immunity. Low levels of this protein have been correlated with recurrent infections. Three polymorphisms in the first exon of the MBL2 gene are responsible for a significant decrease in serum protein levels. 1 The polymorphism at codon 54 is implicated in HIV-1 infection in homosexual transmission 2 and AIDS progression in perinatally-exposed children. 3 Two allelic variants in the MBL2 promoter region were described by Madsen et al; 4 the guanine at position −550 (allele H) and at position −221 (allele Y). These alleles have been correlated with higher MBP levels, while the cytosine at position −550 and at position −221 (allele L and X, respectively) have been correlated with lower levels of this protein. Moreover a deletion of 6 bp has been recently described in the promoter region of MBL2 gene. 5 In order to evaluate the influence of the MBL2 promoter on HIV-1 infection and AIDS progression this region was sequenced in perinatally-exposed children. 
Results and Discussion
The frequency of allele H at position −550 was significantly higher in the 27 HIV-exposed but uninfected children (Group B) (0.48) than in the 90 HIV-infected patients (Group A) (0.31; P = 0.0214), but not different from the 74 healthy Italian controls (Group C) (0.36) ( Table 1 ). The frequency of allele H in rapid progressors (RP) (0.41) was similar to that in slow progressors (SP) (0.30), but the homozygous genotype for the allele H was more frequent in RP (0.23) than in SP (0.05; P = 0.0194) ( Table 1) . This genotype confers a relative risk of 5.4 (95% confidence limits: 1.16-24.93) for a rapid progression to AIDS. Conversely, HIV-1 infected children with phenotype L were protected from a rapid AIDS progression (P = 0.0003, RR = 0.0955; 95% confidence limits: 0.02-0.40) ( Table 1) .
The frequency of allele Y was 0.76 in the 67 patients of Group A, 0.78 in the 23 children of Group B, and 0.78 in 58 subjects of Group C. Also, the genotype and phenotype frequencies did not show any differences.
At position −328, the deletion of six bases (-328delAAAGAG) showed similar allelic and genotype frequencies among the 87 patients of Group A, 25 of Group B and 74 controls of Group C (Table 1 ). Whereas the frequency of patients with the deletion was significantly higher in Group A (0.48) than in Group B (0.24; P = 0.0306) ( Table 1 ). The presence of this deletion confers a relative risk of 2.956 (95% confidence limits: 1.07-8.11) for HIV-1 infection.
Genotype frequencies for polymorphisms of the pro-347 Table 1 Frequencies of polymorphisms at postion −550 and −328 of the promoter region of MBL2 in healthy Italian subjects (Group C) and in children perinatally exposed to HIV-1 with (Group A) and without (Group B) infection. HIV-1 positive children were also subdivided in rapid progressors (RP) and slow progressors (SP) moter region of the MBL2 agree with the Hardy-Weinberg equilibrium. A significant linkage disequilibrium was observed between the deletion at position −328 and L allele at position −550 in healthy Italian population (⌬ = 0.021; P = 0.0421), in RP (⌬ = 0.075; P = 0.0113) and in HIV exposed-uninfected (⌬ = 0.042; P = 0.0367). In SP children the gametic association was observed to be in the same direction, but was not significant (⌬ = 0.027; P = NS).
Our study demonstrated that the polymorphism at position −550 influences HIV-1 infection as well as AIDS progression. Higher levels of MBP may explain a resistance to HIV-1 infection, however, when infected, subjects with high serum concentrations of this protein, may progress to AIDS more rapidly. This paradoxical role of MBP could be explained by the ability to activate the classical pathway of the complement on the HIV particle, giving an advantage to high producers of this protein. Once infected, high producers of MBP may be, however, more susceptible to AIDS progression, as the MBP could supply another key to HIV-1 for cellular infection. In fact Robinson et al 6 have demonstrated in vitro that the HIV-1 virus is able to use the complement receptor (CR2) for its entry into phagocytes. The findings of Garred et al 2 may also help explain the paradoxical role of MBP. It could be that in children and adults the high MBL levels influence the disease differently. Their immune systems may eliminate pathogens in various MBL-dependent ways.
The role of the deletion in the promoter region of the gene in influencing MBP basal levels and HIV susceptibility should be confirmed, although it seems to be determined by its linkage disequilibrium with the L allele at position −550.
In conclusion the influence of MBP on HIV-1 vertical transmission and AIDS progression can be ascribed to two different actions. The first one involves the codifying region of MBL2 gene which modifies the structure of the protein. The second involves the promoter region by regulating the quantity of the protein in the serum.
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Materials and methods
The population studied included 90 Italian children with perinatal HIV-1 infection (Group A). Patients were divided into two groups depending on their disease progression. The first group included 22 patients who were rapid progressors (RP), and developed severe clinical manifestations within the first 2 years of life (category C of the CDC revised classification system for HIV infection in children); 7 the second group included 58 slow progressors (SP), who had neither progressed to category 'C' nor developed severe immunosuppression beyond 8 years of age (CDC immunological category 3). Ten children with an intermediate disease course were excluded from this analysis. Twenty-seven HIV-1-perinatally exposed but uninfected Italian children (Group B) were also investigated; 74 healthy unrelated Italian subjects matched for ethnic origin served as controls (Group C).
DNA was isolated from EDTA-collected peripheral whole blood using standard laboratory techniques. 8 The PCR reactions were performed under standard conditions in 50 L final volume using 10 pmol of each primer (5ЈCCAGGGCCAACGTAGTAAGAAA 3Ј, forward primer; 5ЈTGGCGTTGCTGCTGGAA 3Ј, reverse primer), and 1 U of AmpliTaq GOLD DNA polymerase (PE Biosystems, Foster City, CA, USA) in a thermal cycler 2400 (PE Biosystems). After 35 cycles at 95°C for 30 sec, 56°C for 30 sec and at 72°C for 30 sec, PCR products were detected in a 3% agarose gel. DNA sequencing of both DNA strands was performed according to the modified Sanger dideoxy method with BigDye Terminator Cycle Sequencing Ready Reaction Kit (PE Biosystems).
Allele frequencies were calculated by direct gene counting and the differences analysed by the Chi-square test using 2 × 2 contingency tables. The relative risk (RR) was calculated according to the Woolf formula, 9 whilst the delta values for linkage disequilibrium were calculated using the software Arlequin 1.1 disposable for non-profit use at the web address http://antrhopologie.unige.ch/ arlequin
